L-DOPA (3,4-Dihydroxy-L-phenylalanine) is a naturally occurring amino acid derivative and a direct metabolic precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline). It is classified as a non-proteinogenic amino acid due to the presence of two hydroxyl groups on the phenyl ring. Its CAS number is 59-92-7, and it is distinct from the provided CAS 27244-64-0, which corresponds to a different tyrosine derivative (2,5-dihydroxy-L-tyrosine). The primary and most significant application of L-DOPA is in the treatment of Parkinson's disease. It is the gold-standard pharmacological therapy, administered to replenish depleted dopamine levels in the brain. As a prodrug, it crosses the blood-brain barrier and is decarboxylated to dopamine by aromatic L-amino acid decarboxylase (AADC). It is also a crucial intermediate in the biosynthesis of melanin and certain alkaloids in plants. Beyond its therapeutic use, L-DOPA serves as an important biochemical reagent in neuroscience and pharmacological research for studying dopaminergic systems. It is also investigated for its potential antioxidant properties. Due to its role as a biosynthetic precursor, it is categorized as a specialized amino acid derivative and a key building block in medicinal chemistry for developing related neuroactive compounds.